Adage Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.7M Sell
989,189
-284,682
-22% -$27.3M 0.13% 155
2025
Q4
$122M Sell
1,273,871
-906,646
-42% -$88.1M 0.19% 104
2025
Q3
$208M Buy
2,180,517
+375,820
+21% +$34.5M 0.33% 46
2025
Q2
$157M Buy
1,804,697
+78,539
+5% +$6.66M 0.27% 67
2025
Q1
$155M Buy
1,726,158
+70,371
+4% +$6.3M 0.29% 65
2024
Q4
$132M Buy
1,655,787
+111,910
+7% +$9.69M 0.23% 80
2024
Q3
$139M Buy
1,543,877
+445,147
+41% +$37.4M 0.25% 80
2024
Q2
$86.5M Buy
1,098,730
+472,150
+75% +$38.7M 0.16% 129
2024
Q1
$54.6M Sell
626,580
-945,349
-60% -$80.7M 0.1% 211
2023
Q4
$129M Buy
1,571,929
+248,399
+19% +$18.9M 0.27% 77
2023
Q3
$104M Buy
1,323,530
+198,000
+18% +$16.6M 0.24% 100
2023
Q2
$99.2M Buy
1,125,530
+180,953
+19% +$15.6M 0.22% 114
2023
Q1
$76.2M Sell
944,577
-187,353
-17% -$15.3M 0.17% 149
2022
Q4
$88M Sell
1,131,930
-61,800
-5% -$5.01M 0.21% 117
2022
Q3
$96.4M Sell
1,193,730
-23,400
-2% -$2.1M 0.24% 102
2022
Q2
$109M Sell
1,217,130
-11,900
-1% -$1.21M 0.25% 83
2022
Q1
$136M Sell
1,229,030
-35,100
-3% -$3.71M 0.26% 83
2021
Q4
$131M Sell
1,264,130
-35,000
-3% -$4.05M 0.24% 92
2021
Q3
$163M Sell
1,299,130
-164,800
-11% -$21.3M 0.32% 61
2021
Q2
$182M Sell
1,463,930
-32,800
-2% -$4.12M 0.36% 53
2021
Q1
$177M Buy
1,496,730
+1,810
+0.1% +$212K 0.36% 53
2020
Q4
$175M Sell
1,494,920
-409,800
-22% -$45.1M 0.38% 49
2020
Q3
$198M Buy
1,904,720
+404,000
+27% +$40.6M 0.5% 35
2020
Q2
$138M Sell
1,500,720
-295,571
-16% -$28.3M 0.35% 55
2020
Q1
$162M Buy
1,796,291
+233,026
+15% +$24.8M 0.48% 37
2019
Q4
$177M Sell
1,563,265
-67,655
-4% -$7.42M 0.44% 44
2019
Q3
$177M Sell
1,630,920
-4,212
-0.3% -$439K 0.44% 47
2019
Q2
$159M Buy
1,635,132
+197,828
+14% +$18.1M 0.4% 57
2019
Q1
$131M Sell
1,437,304
-74,711
-5% -$6.69M 0.33% 82
2018
Q4
$138M Buy
1,512,015
+7,580
+0.5% +$708K 0.38% 67
2018
Q3
$148M Buy
1,504,435
+55,200
+4% +$5.1M 0.33% 77
2018
Q2
$124M Sell
1,449,235
-173,796
-11% -$14.5M 0.28% 87
2018
Q1
$130M Sell
1,623,031
-144,118
-8% -$11.9M 0.3% 86
2017
Q4
$143M Buy
1,767,149
+341,160
+24% +$27.3M 0.32% 79
2017
Q3
$111M Sell
1,425,989
-205,200
-13% -$17M 0.27% 93
2017
Q2
$145M Sell
1,631,189
-117,000
-7% -$9.87M 0.35% 65
2017
Q1
$141M Buy
1,748,189
+521,700
+43% +$40.8M 0.35% 72
2016
Q4
$87.4M Sell
1,226,489
-567,300
-32% -$44.6M 0.24% 114
2016
Q3
$155M Buy
1,793,789
+22,080
+1% +$1.92M 0.43% 62
2016
Q2
$154M Sell
1,771,709
-215,900
-11% -$17.5M 0.42% 69
2016
Q1
$149M Sell
1,987,609
-260,338
-12% -$19.6M 0.4% 70
2015
Q4
$173M Sell
2,247,947
-427,000
-16% -$32.1M 0.45% 55
2015
Q3
$179M Sell
2,674,947
-251,400
-9% -$18.5M 0.5% 46
2015
Q2
$217M Sell
2,926,347
-50,000
-2% -$3.82M 0.54% 34
2015
Q1
$232M Buy
+2,976,347
New +$226M 0.57% 25
2014
Q2
Sell
-514,097
Closed -$31.6M 723
2014
Q1
$31.6M Sell
514,097
-640,700
-55% -$37.3M 0.09% 281
2013
Q4
$66.3M Buy
1,154,797
+283,000
+32% +$16M 0.18% 167
2013
Q3
$46.4M Sell
871,797
-868,000
-50% -$46.7M 0.13% 209
2013
Q2
$89.5M Buy
+1,739,797
New +$86M 0.28% 101

Other funds holding MDT

Adage Capital Partners's MDT Position: Q1 2026 in Review

Adage Capital Partners reduced its Medtronic (MDT) stake by 22% in Q1 2026, selling an estimated $27.3M and leaving 989,189 shares worth $85.7M. The position accounts for 0.13% of the portfolio, ranked #155.

Adage Capital Partners first reported a position in MDT in Q2 2013 and has held it in 49 quarters since. The position peaked at $232M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Adage Capital Partners held 989,189 shares of Medtronic worth $85.7M as of Q1 2026.
  • Adage Capital Partners sold 284,682 Medtronic shares in Q1 2026, an estimated $27.3M.
  • Medtronic made up 0.13% of Adage Capital Partners's portfolio in Q1 2026, its #155 holding.
  • Adage Capital Partners first reported a position in Medtronic in Q2 2013 and has held it in 49 quarters since.
  • Adage Capital Partners's Medtronic position peaked at $232M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.